To achieve long-term diabetic complication reduction and decrease the health care costs, all diabetic patients must have access to the components of diabetes care modality, such as medications, supplies, and self-management education programs. However, our current government policies for diabetic patients are not sufficient to allow for adequate blood glucose control. Our national insurer does not reimburse for diabetes supplies such as blood glucose testing monitors, blood glucose test strips, lancet devices and lancets, insulin syringes and pen needles, and alcohol swabs. The government officer states that national laws, regulations, executive order, and financial problems prohibit the reimbursement of diabetes supplies. However, to achieve good outcomes and decrease the public burden of medical care costs, all stake holders, health care professionals, and diabetic patients should exert effort to require reimbursement of diabetic supplies.

